Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven salvage approach

Abstract

Aoki, T., Izutsu, K., Suzuki, R., Nakaseko, C., Arima, H., Shimada, K., Tomita, A., Sasaki, M., Takizawa, J., Mitani, K., Igarashi, T., Maeda, Y., Fukuhara, N., Ishida, F., Niitsu, N., Ohmachi, K., Takasaki, H., Nakamura, N., Kinoshita, T., Nakamura, S. & Ogura, M. (2014) Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan. Haematologica, 99, 1817–1825. Aoki, T., Shimada, K., Suzuki, R., Izutsu, K., Tomita, A., Maeda, Y., Takizawa, J., Mitani, K., Igarashi, T., Sakai, K., Miyazaki, K., Mihara, K., Ohmachi, K., Nakamura, N., Takasaki, H., Kiyoi, H., Nakamura, S., Kinoshita, T. & Ogura, M. (2015) High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma. Blood Cancer Journal, 5, e372. Atsuta, Y. (2016) Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). International Journal of Hematology, 103, 3–10. Avivi, I., Boumendil, A., Finel, H., Nagler, A., de Sousa, A.B., Santasusana, J.M.R., Vandenberghe, E., Afanasyev, B., Bordessoule, D., Moraleda, J.M., Garcia, E.C., Pohlreich, D., Garcia, G.G., Thomson, K., Or, R., Beelen, D., Zuffa, E., Giebel, S., Berthou, C., Salles, G., Melpignano, A., Montoto, S. & Dreger, P. (2018) Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation, 53, 1001–1009. Fenske, T.S., Ahn, K.W., Graff, T.M., DiGilio, A., Bashir, Q., Kamble, R.T., Ayala, E., Bacher, U., Brammer, J.E., Cairo, M., Chen, A., Chen, Y.B., Chhabra, S., D’Souza, A., Farooq, U., Freytes, C., Ganguly, S., Hertzberg, M., Inwards, D., Jaglowski, S., Kharfan-Dabaja, M.A., Lazarus, H.M., Nathan, S., Pawarode, A., Perales, M.A., Reddy, N., Seo, S., Sureda, A., Smith, S.M. & Hamadani, M. (2016) Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. British Journal of Haematology, 174, 235–248. Giulino-Roth, L. (2018) How I treat primary mediastinal B-cell lymphoma. Blood, 132, 782–790. Herrera, A.F., Chen, L., Khajavian, S., Chase, M.L., Darrah, J., Maloney, D.G., Ho, V.T., Soiffer, R.J., Antin, J.H., Forman, S.J., Nademanee, A.P., Chen, Y.-B., Armand, P. & Shadman, M. (2018) Allogeneic stem cell transplantation provides durable remission in patients with primary mediastinal large B-cell lymphoma. Blood, 132, 2177–2177. Nath, S. & Seymour, J. (2005) Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation. Leukemia & lymphoma, 46, 1075–1079. Rashidi, A., Ebadi, M. & Cashen, A.F. (2016) Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis. Bone Marrow Transplantation, 51, 521–528. Shah, N., Szabo, A., Huntington, S., Epperla, N., Reddy, N., Ganguly, S., Vose, J., Obiozor, C., Faruqi, F., Kovach, A., Costa, L., Xavier, A., Okal, R., Kanate, A., Ghosh, N., Kharfan-Dabaja, M., Strelec, L., Hamadani, M., Fenske, T., Calzada, O., Cohen, J., Chavez, J. & Svoboda, J. (2018) R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. British Journal of Haematology, 180, 534–544.